alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2017178EN.01003001.xml

| 6.6.2017 | EN | Official Journal of the European Union | C 178/30 |
| --- | --- | --- | --- |

6.6.2017

EN

Official Journal of the European Union

C 178/30

---

Action brought on 12 April 2017 — HF v Parliament

(Case T-218/17)

(2017/C 178/44)

Language of the case: French

Parties

Parties

Applicant: HF (represented by: A. Tymen, lawyer)

Applicant:

Defendant: European Parliament

Defendant:

Form of order sought

Form of order sought

| — | Declare the present action admissible and well-founded;
  In consequence, |
| --- | --- |

—

Declare the present action admissible and well-founded;

In consequence,

| — | Annul the decision of 3 June 2016 rejecting the applicant’s request for assistance of 11 December 2014; |
| --- | --- |

—

Annul the decision of 3 June 2016 rejecting the applicant’s request for assistance of 11 December 2014;

| — | Insofar as necessary, annul the decision of 4 January 2017, received on 11 January 2017, rejecting the applicant’s claim of 6 September 2016; |
| --- | --- |

—

Insofar as necessary, annul the decision of 4 January 2017, received on 11 January 2017, rejecting the applicant’s claim of 6 September 2016;

| — | Order the defendant to pay damages set ex aequo et bono at EUR 90 000 in compensation of the non-pecuniary harm suffered by the applicant; |
| --- | --- |

—

Order the defendant to pay damages set ex aequo et bono at EUR 90 000 in compensation of the non-pecuniary harm suffered by the applicant;

ex aequo et bono

| — | Order the defendant to pay all the costs. |
| --- | --- |

—

Order the defendant to pay all the costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on three pleas in law.

| 1. | First plea in law, alleging infringement of the rights of the defence, infringement of Article 41 of the Charter of Fundamental Rights of the European Union, infringement of the right to be heard and infringement of the principle of an adversarial process. |
| --- | --- |

1.

First plea in law, alleging infringement of the rights of the defence, infringement of Article 41 of the Charter of Fundamental Rights of the European Union, infringement of the right to be heard and infringement of the principle of an adversarial process.

| 2. | Second plea in law, alleging procedural errors such as to vitiate the contested decision and partiality in the procedure followed by the Committee. |
| --- | --- |

2.

Second plea in law, alleging procedural errors such as to vitiate the contested decision and partiality in the procedure followed by the Committee.

| 3. | Third plea in law, alleging a manifest error of assessment, [infringement] of the obligation to provide assistance and the duty of care and infringement of Articles 12a and 24 of the Staff Regulations. |
| --- | --- |

3.

Third plea in law, alleging a manifest error of assessment, [infringement] of the obligation to provide assistance and the duty of care and infringement of Articles 12a and 24 of the Staff Regulations.

---
[Federal Register Volume 66, Number 99 (Tuesday, May 22, 2001)]
[Notices]
[Page 28205]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13015]



[[Page 28205]]

=======================================================================
-----------------------------------------------------------------------

NATIONAL CREDIT UNION ADMINISTRATION


Notice of Change in Subject of Meeting

    The National Credit Union Administration Board determined that its 
business required the deletion of the following item from the 
previously announced closed meeting (Federal Register, Vol. 66, No. 93, 
page 24409, May 14, 2001) scheduled for Thursday, May 17, 2001:
    2. One (1) Personnel Matter. Closed pursuant to exemptions (2) and 
(6).
    The Board voted unanimously that agency business required that this 
item be removed from the closed agenda. Earlier announcement of this 
change was not possible.
    The previously announced items were:
    1. Administrative Action under Part 704 of NCUA's Rules and 
Regulations. Closed pursuant to exemption (8).
    2. Two (2) Personnel Matters. Closed pursuant to exemptions (2) and 
(6).

FOR FURTHER INFORMATION CONTACT: Becky Baker, Secretary of the Board, 
Telephone (703) 518-6304.

Becky Baker,
Secretary of the Board.
[FR Doc. 01-13015 Filed 5-18-01; 12:51 pm]
BILLING CODE 7535-01-M
No. 404.

#### Charles Gring, Petitioner, *v.*Chesapeake & Delaware Canal Company.

October 19, 1908.

Petition for a writ of certiorari to the United States Circuit Court of Appeals for the Fourth Circuit denied.. *Mr. Robert H. Smith*and *Mr. Jacob France*for petitioner. *Mr. Andrew C. Gray*for respondent.
Exhibit 32

RESERVENET, INC.
CERTIFICATION PURSUANT TO SARBANES-OXLEY SECTION 1350,

In connection with the Annual Report of ReserveNet, Incorporated (the "Company")
on Form  10-KSB  for the  period  ending  December  31,  2003 as filed  with the
Securities  and Exchange  Commission on the date hereof (the Report),  I, Daniel
Regidor, Chief Financial Officer of the Company,  certify, pursuant to 18 U.S.C.
ss.1350,  as adopted pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002,
that to my knowledge:

     (1) The Report fully  complies  with the  requirements  of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Date:  April 7, 2004
       ---------------

/s/ Daniel Regidor
------------------------------------------
Daniel Regidor
President, Chief Executive Officer, Chief Financial Officer, and Secretary
# C_2019072EN.01002601.xml

| 25.2.2019 | EN | Official Journal of the European Union | C 72/26 |
| --- | --- | --- | --- |

25.2.2019

EN

Official Journal of the European Union

C 72/26

---

Judgment of the General Court of 12 December 2018 — Mubarak v Council

(Case T-358/17) (1)

((Common foreign and security policy - Restrictive measures taken in view of the situation in Egypt - Freezing of funds - Objectives - Criteria for inclusion of persons targeted - Maintenance of the applicant’s designation on the list of persons targeted - Factual basis - Plea of illegality - Legal basis - Proportionality - Right to a fair trial - Presumption of innocence - Principle of good administration - Error of law - Manifest error of assessment - Right to property - Rights of defence - Right to effective judicial protection))

(2019/C 72/33)

Language of the case: English

Parties

Applicant: Mohamed Hosni Elsayed Mubarak (Cairo, Egypt) (represented by: B. Kennelly QC, J. Pobjoy, Barrister, G. Martin, M. Rushton and C. Enderby Smith, Solicitors)

Defendant: Council of the European Union (represented initially by: J. Kneale and M. Veiga, and subsequently by J. Kneale and A. Sikora-Kalėda, acting as Agents)

Re:

Application under Article 263 TFEU for annulment (i) of Council Decision (CFSP) 2017/496 of 21 March 2017 amending Decision 2011/172/CFSP concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Egypt (OJ 2017 L 76, p. 22); (ii) of Council Implementing Regulation (EU) 2017/491 of 21 March 2017 implementing Regulation (EU) No 270/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Egypt (OJ 2017 L 76, p. 10); (iii) of Council Decision (CFSP) 2018/466 of 21 March 2018 amending Decision 2011/172/CFSP concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Egypt (OJ 2018 L 78I, p. 3); and (iv) of Council Implementing Regulation (EU) 2018/465 of 21 March 2018 implementing Regulation (EU) No 270/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in Egypt (OJ 2018 L 78I, p. 1), in so far as those acts apply to the applicant.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Mr Mohamed Hosni Elsayed Mubarak to bear his own costs and to pay those incurred by the Council of the European Union. |
| --- | --- |

2.

Orders Mr Mohamed Hosni Elsayed Mubarak to bear his own costs and to pay those incurred by the Council of the European Union.

---

(1)  OJ C 239, 24.7.2017.

---
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

THE STATE OF TEXAS,

 State,

v.

CHRISTOPHER SCOTT ADAMS,

 

 Appellee.

 

§

§

§

 

§

§

§ 

 

§

'

'

No. 08-14-00088-CR

Appeal from the

243rdJudicial District Court

of El Paso County, Texas 

(TC# 20130D03661)

 O R D E R

The Court GRANTS the Appellee’s third motion for extension of time to file the brief until 

January 16, 2015. NO FURTHER MOTIONS FOR EXTENSION OF TIME TO FILE THE 

APPELLEE’S BRIEF WILL BE CONSIDERED BY THIS COURT.

It is further ORDERED that the Hon. James D. Lucas, the Appellee’s Attorney, prepare the 

Appellee’s brief and forward the same to this Court on or before January 16, 2015.

IT IS SO ORDERED this 19th day of December, 2014.

PER CURIAM

Before McClure, C.J., Rodriguez, and Hughes, JJ.
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 1 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 2 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 3 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 4 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 5 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 6 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 7 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 8 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 9 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 10 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 11 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 12 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 13 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 14 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 15 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 16 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 17 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 18 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 19 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 20 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 21 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 22 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 23 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 24 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 25 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 26 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 27 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 28 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 29 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 30 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 31 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 32 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 33 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 34 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 35 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 36 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 37 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 38 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 39 of 40
Case 1:07-cv-05804-GEL Document 18-11 Filed 05/02/2008 Page 40 of 40
exv10w1w5






Exhibit 10.1.5




FIFTH AMENDMENT TO SHAREHOLDER LOAN AGREEMENT




THIS FIFTH AMENDMENT TO THE SHAREHOLDER LOAN AGREEMENT IS DATED THE 29th DAY OF JULY, 2010 AND MADE
BETWEEN:





	 	1.	 	AMERICAN CAPITAL, LTD., a company incorporated under the laws of Delaware, with
registered office at 2 Bethesda Metro Center, 14th Floor, Bethesda, MD 20814 (hereafter the
“Lender”): and
	 
	 	2.	 	DOSIMETRY ACQUISITIONS (FRANCE), a simplified joint stock company (societé par actions
simplifiée) company incorporated under the laws of France, with registered office at
Lieu-dit “Calés”, 13113 Lamanon (France), with registration number 453 885 626 R.C.S.
Tarascon, (hereafter the “Borrower”).




WHEREAS:





	 	1.	 	Lender and Borrower are party to a Shareholder Loan Agreement dated 23 September 2005,
which has been amended (the “Initial Loan Agreement”).






	 	2.	 	Lender and Borrower have agreed to extend the maturity date of the Initial Loan
Agreement and in this context have agreed to enter into this Fourth Amendment to the
Shareholder Loan Agreement (the “Agreement”).





IT IS AGREED AS FOLLOWS:





	 	1.	 	Definitions.
	 
	 	 	 	In this Agreement (including the above recitals), all capitalized terms and expressions not
otherwise defined herein shall have the meaning ascribed to them in the Initial Loan
Agreement.
	 
	 	2.	 	Amendment to the Initial Loan Agreement
	 
	 	 	 	The Parties hereby agree to amend the definition of “Repayment Date” in Article 1
(Definitions) of the Initial Loan Agreement as follows:






	 	 	 	“ “Repayment Date” means 1 July 2011.”






	 	3.	 	Other Provisions of the Initial Loan Agreement
	 
	 	 	 	Any and all other provisions of the Initial Loan Agreement shall remain in full force and
effect.




 









 








	 	4.	 	Governing Law
	 
	 	 	 	This Agreement shall be governed by and construed in accordance with the laws of France.
	 
	 	5.	 	Jurisdiction
	 
	 	 	 	The parties irrevocably agree that the Commercial Court of Paris is to have exclusive
jurisdiction to settle any disputes which may arise out of or in connection with this Agreement.
	 
	 	 	 	On the date stated at the beginning of this Agreement, in two (2) original copies





	 	 	 	 	 	 	 	 	 

	LENDER:	 	BORROWER:	 	 
	 
	 	 	 	 	 	 	 	 
	American Capital, Ltd.	 	Dosimetry Acquisitions (France)	 	 
	 
	 	 	 	 	 	 	 	 
	By: 

	/s/ Robert Klein	 	 	By:
	 	 /s/ Thomas D. Logan	 	 
	 	 

Robert Klein 

Duly Authorized thereto

	 	 	 	 	 

Thomas D. Logan

Duly Authorized thereto
	 	 






[Signature Page to Fifth Amendment to DAF Shareholder Loan Agreement]
# C_2019399EN.01001101.xml

| 25.11.2019 | EN | Official Journal of the European Union | C 399/11 |
| --- | --- | --- | --- |

25.11.2019

EN

Official Journal of the European Union

C 399/11

---

Judgment of the Court (Fifth Chamber) of 18 September 2019 (request for a preliminary ruling from the Fővárosi Közigazgatási és Munkaügyi Bíróság — Hungary) — VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet

(Case C-222/18) (1)

(Reference for a preliminary ruling - Cross-border healthcare - Directive 2011/24/EU - Articles 3(k) and 11(1) - Prescription - Definition - Recognition of a prescription issued in another Member State by an authorised person - Conditions - Free movement of goods - Prohibition of measures having equivalent effect to quantitative restrictions on exports - Articles 35 and 36 TFEU - Restriction on the dispensing by a pharmacy of prescription-only medicinal products - Order form issued in another Member State - Justification - Protection of human health and human life - Directive 2001/83/EC - Second paragraph of Article 81 - Supply of medicinal products to the public of a Member State)

(2019/C 399/12)

Language of the case: Hungarian

Referring court

Fővárosi Közigazgatási és Munkaügyi Bíróság

Parties to the main proceedings

Applicant: VIPA Kereskedelmi és Szolgáltató Kft.

Defendant: Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet

Operative part of the judgment

Article 3(k) and Article 11(1) of Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare must be interpreted as not precluding legislation of a Member State under which it is not permissible for a pharmacy in that Member State to dispense prescription-only medicinal products on the basis of an order form where that order form has been issued by a healthcare professional authorised to prescribe medicinal products and to exercise his activity in another Member State, whereas such dispensing of those products is permitted where that order form has been issued by a healthcare professional authorised to exercise his activity in the first Member State, bearing in mind that, under that legislation, such order forms do not contain the name of the patient concerned.

Articles 35 and 36 TFEU must be interpreted as not precluding such legislation of a Member State, in so far as that legislation is justified by the objective of protecting human health and human life, is appropriate for securing the attainment of that objective and does not go beyond what is necessary to attain it, which is for the national court to determine.

---

(1)  OJ C 221 25.06.2018.

---
**Exhibit
      32.1**





**Certification
      of Principal Executive Officer**


**Pursuant
      to 18 U.S.C. Section 1350, as adopted pursuant to**


**Section
      906 of the Sarbanes-Oxley Act of 2002**





In
      connection with the Quarterly Report of SRKP 15, Inc. (the "Company") on Form
      10-Q for the period ended June 30, 2008 as filed with the Securities and
      Exchange Commission on the date hereof (the "Report"), I, Richard A. Rappaport,
      certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
      906
      of the Sarbanes-Oxley Act of 2002, that:





(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





/s/
                Richard A. RappaportRichard
                A. RappaportPrincipal
                Executive OfficerAugust
                1, 2008
Exhibit 32.1





CERTIFICATION





Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, the undersigned officer of TheraBiogen, Inc. (the “Company”), does hereby certify, to such officer’s knowledge, that:





(1)    The quarterly report on form 10-q / a of the Company for the annual period ended August 31, 2010 (“the Report”) fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and





(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.






Company NameDate: June 15, 2011
By:
/s/ Kelly T. HickelKelly T. HickelChief Executive OfficerPrincipal Accounting Officer





A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Russell G. Felten, Chief Executive Officer of DTLL, Inc., certify that:



1.

I have reviewed this report on Form 10-KSB of DTLL, Inc.



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;



4.

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:



(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)

Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)

Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and



5.

The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):



(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and



(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.





Date: August 30, 2004

/s/ Russell G. Felten



Russell G. Felten

Chief Executive Officer



---